We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
(+16%)
Cap. Flow
+$7.6B
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.28B |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$351M |
| 4 |
Apple
AAPL
|
+$302M |
| 5 |
Wells Fargo
WFC
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$685M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$566M |
| 3 |
Entergy
ETR
|
+$367M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$340M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.22% |
| 2 | Technology | 11.9% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Communication Services | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Smith & Nephew
SNN
$13.3B
| $817K | ﹤0.01% |
17,000
+9,804
| +136% | +$442K |
|
|
INFN
3177
DELISTED
Infinera Corporation Common Stock
INFN
| $815K | ﹤0.01% |
102,652
-23,249
| -18% | -$143K |
|
3178
Unitil
UTL
$970M
| $814K | ﹤0.01% |
13,171
-1,117
| -8% | -$69K |
|
|
SEAC
3179
DELISTED
Seachange International Inc
SEAC
| $814K | ﹤0.01% |
+9,712
| New | +$660K |
|
|
USCR
3180
DELISTED
U S Concrete, Inc.
USCR
| $812K | ﹤0.01% |
19,498
+3,965
| +26% | +$181K |
|
3181
Appian
APPN
$1.98B
| $811K | ﹤0.01% |
21,224
-4,591
| -18% | -$198K |
|
3182
Orthofix Medical
OFIX
$477M
| $811K | ﹤0.01% |
17,564
+1,711
| +11% | +$80.4K |
|
|
SASR
3183
DELISTED
Sandy Spring Bancorp Inc
SASR
| $811K | ﹤0.01% |
21,427
-5,159
| -19% | -$182K |
|
|
ALXN
3184
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $811K | ﹤0.01% |
7,500
| – | – |
|
3185
MGP Ingredients
MGPI
$379M
| $810K | ﹤0.01% |
16,721
+4,119
| +33% | +$193K |
|
|
SP
3186
DELISTED
SP Plus Corporation
SP
| $806K | ﹤0.01% |
18,999
+1,366
| +8% | +$57.4K |
|
3187
Sabesp
SBS
$19.1B
| $804K | ﹤0.01% |
275,482
-11,231
| -4% | -$28.8K |
|
3188
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $801K | ﹤0.01% |
13,808
| – | – |
|
3189
PUT
Galicia Financial Group
GGAL
$7.99B
| $795K | ﹤0.01% |
+49,000
| New | +$647K |
|
3190
Cheniere Energy
CQP
$31.9B
| $794K | ﹤0.01% |
19,932
+4,265
| +27% | +$179K |
|
|
ISEE
3191
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $794K | ﹤0.01% |
+92,485
| New | +$330K |
|
3192
Acco Brands
ACCO
$389M
| $792K | ﹤0.01% |
84,644
-6,459
| -7% | -$61.2K |
|
3193
ATN International
ATNI
$366M
| $792K | ﹤0.01% |
14,299
+2,400
| +20% | +$136K |
|
3194
Avantis Emerging Markets Equity ETF
AVEM
$25.4B
| $792K | ﹤0.01% |
14,407
-179,474
| -93% | -$9.28M |
|
3195
1st Source
SRCE
$2.16B
| $792K | ﹤0.01% |
15,274
-2,617
| -15% | -$131K |
|
|
NXGN
3196
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $792K | ﹤0.01% |
49,268
-5,927
| -11% | -$97.9K |
|
|
SDRL
3197
DELISTED
Seadrill Limited Common Stock
SDRL
| $792K | ﹤0.01% |
312,046
+163,935
| +111% | +$271K |
|
3198
Arcos Dorados Holdings
ARCO
$1.72B
| $788K | ﹤0.01% |
99,964
+7,389
| +8% | +$53.3K |
|
3199
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
| $787K | ﹤0.01% |
10,833
-16,937
| -61% | -$1.18M |
|
3200
BridgeBio Pharma
BBIO
$15.7B
| $780K | ﹤0.01% |
+22,232
| New | +$616K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2019 Portfolio in Review
As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.
- Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
- Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
- Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
- Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
- Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
- Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.